Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT03397121 · COMPLETED
Trial details
- NCT number
- NCT03397121
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2019-08-27
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.